Iatrogenic Immunosuppression and Cutaneous Malignancy
Clinics in Dermatology
Patients with autoimmune and inflammatory conditions often receive long-term immunosuppressive therapy. Some of the largest patient populations with iatrogenic immunosuppression include patients who have received solid-organ transplants or who have rheumatoid arthritis or psoriasis. Although treatments improve patient outcomes, individuals with immunosuppression subsequently may have an increased risk of skin cancer, including squamous cell carcinoma, basal cell carcinoma, and malignant melanoma.
DePry JL, Reed KB, Cook-Norris RH, Brewer JD. Iatrogenic Immunosuppression and Cutaneous Malignancy. Clinics in Dermatology. 2011; 29(6). doi: 10.1016/j.clindermatol.2011.08.009.